Department of Gastrointestinal Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Oper Neurosurg (Hagerstown). 2023 Mar 1;24(3):232-241. doi: 10.1227/ons.0000000000000493. Epub 2022 Nov 10.
Robotic surgery may be advantageous in neurogenic sacral tumor resection but only a few studies reported robotic-assisted neurogenic sacral tumor resection.
To propose a new surgical strategy for robotic-assisted benign sacral neurogenic tumor resection and introduce the ultrasonic osteotomy surgical system in robotic surgery.
Twelve patients who had robotic-assisted primary benign sacral neurogenic tumor resection between May 2015 and March 2021 were included. Our surgical strategy divides tumors into 4 types. Type I: Presacral tumors with diameter <10 cm. Type II: Narrow-base tumors involving the sacrum with diameter <10 cm. Type III: Broad-base tumors involving the sacrum with diameter <10 cm. Type IV: Tumors involving sacral nerve roots ≥2 levels and/or with diameter ≥10 cm.
Five type I, 5 type II, and 1 type III patients underwent tumor resection via an anterior approach, and 1 type IV patient via a combined approach. The median operation time, blood loss, and postoperative hospital stay of type I and II were much less than those of type IV. The ultrasonic osteotomy surgical system facilitated osteotomy in 2 type II and 1 type III patients. Eleven patients had total resections, and 1 type III patient had a partial resection. During the follow-up period of 7.9 to 70.9 months (median: 28.5 months), no local recurrences or deaths were noted.
With the largest single-center series to our knowledge, this surgical strategy helped to guide robotic-assisted benign sacral neurogenic tumor resection. The ultrasonic osteotomy surgical system was effective for type II and III.
机器人手术在治疗脊索瘤方面可能具有优势,但仅有少数研究报道了机器人辅助治疗脊索瘤。
提出一种新的机器人辅助良性骶神经源性肿瘤切除术的手术策略,并介绍机器人手术中的超声骨切割系统。
纳入 2015 年 5 月至 2021 年 3 月间接受机器人辅助原发性良性骶神经源性肿瘤切除术的 12 例患者。我们的手术策略将肿瘤分为 4 型。Ⅰ型:肿瘤位于骶前,直径<10cm;Ⅱ型:累及骶骨的基底较窄的肿瘤,直径<10cm;Ⅲ型:累及骶骨的基底较宽的肿瘤,直径<10cm;Ⅳ型:累及≥2 个骶神经根且/或直径≥10cm的肿瘤。
5 例Ⅰ型、5 例Ⅱ型和 1 例Ⅲ型患者经前路切除肿瘤,1 例Ⅳ型患者经联合入路切除肿瘤。Ⅰ型和Ⅱ型患者的中位手术时间、出血量和术后住院时间均明显少于Ⅳ型患者。超声骨切割系统辅助 2 例Ⅱ型和 1 例Ⅲ型患者完成了骨切开术。11 例患者行全切除,1 例Ⅲ型患者行部分切除。在 7.9 至 70.9 个月(中位:28.5 个月)的随访期间,未观察到局部复发或死亡。
该手术策略为机器人辅助治疗良性骶神经源性肿瘤提供了指导,基于我们所知,这是最大的单中心系列研究。超声骨切割系统对于Ⅱ型和Ⅲ型肿瘤有效。